My father was a cardiothoracic surgeon who invented the intra-aortic balloon pump, an innovation that transformed cardiac care and saved countless lives. And yet, he died young from an obesity-related illness.

Today, we have the science. We have medications that can meaningfully treat obesity. But far too many people still can’t access them—and people die every day because of it. The deeper I looked into the system, the more frustrated—and motivated—I became.

That’s why, after more than 20 years as an entrepreneur, and after founding and selling four companies, I was ready to take on something bigger. Something many people said was impossible. I started Andel to fix how brand-name drugs are priced and distributed in America—so patients can actually get the treatments they need.

For decades, the system has rewarded treating disease after it appears, because that’s when insurance pays. But the future of healthcare is prevention: taking medications not as a sign of sickness, but to stay healthy in the first place. Andel is building a simple service—designed like a subscription—that connects people to the medicines they need at a price we can all afford.

In many ways, Andel allows me to finish the work my father started.